Login

Enzymatica presents positive in-vitro results | August 2023 - Claus Egstrand,CEO, Enzymatica AB (publ) 00:00:00

Share On Facebook Share On Twitter

Enzymatica presents positive in-vitro results | August 2023

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Build business relationships that feel like family|Jim Powers,President & Chief Financial Officer,Tacony Corporation
00:10:00
Key Takeaways from Q1 Earnings Season Around the World | Michelle Batjargal - Equity Manager Research Analyst at Russell Investments.
00:10:00
Fran Horowitz on Abercrombie & Fitch: Evolving Trends, New Openings, and Leadership Advice | Fran Horowitz, CEO , Abercrombie & Fitch Co.
00:00:00
Stephen Patrick, CEO, OptiBiotix Health
00:10:00
Navigating the Future of Energy: Rhett Bennett on Black Mountain's Expansion and the Critical Role of Nickel | Rhett Bennett, CEO, Black Mountain Energy Ltd.
00:10:00
Childhood Memories and Sibling Bonds|Madison Farkas,Professor,University of Wisconsin
00:10:00
AGAT Laboratories: Core Values and Company Purpose.
00:10:00
Mike Salvino, President and CEO of DXC, shares leadership advice with Marietta College's graduating class.|Raul Fernandez is president and chief executive officer of DXC Technology
00:10:00
Peel Mining: Advancing High-Grade Base Metal Projects in Western New South Wales
00:10:00
invest with fast commits and high conviction and they strive to be proactively helpful|Cindy Bi,General Partner,CapitalX
00:10:00
Celebrating Innovation: Seeking the Most Innovative SME with CHF 17,000 in Prize Money | Johann Reiter, CEO, Vetropack Holding AG.
00:00:00
James Czirr, Executive Chairman of Galectin Therapeutics, Inc.

© 2017 - Neuhu+